Targeting protein-protein interaction interfaces in COVID-19 drug discovery

Targeting protein-protein interaction interfaces in COVID-19 drug discovery

To date, the COVID-19 pandemic has claimed over 1 million human lives, infected another 50 million individuals and wreaked havoc on the global economy. The crisis has spurred the ongoing development of drugs targeting its etiological agent, the SARS-CoV-2. Targeting relevant protein-protein interact...

Full description

Bibliographic Details
Main Authors: Chung-ke Chang, Shan-Meng Lin, Roshan Satange, Shih-Chao Lin, Sin-Cih Sun, Hung-Yi Wu, Kylene Kehn-Hall, Ming-Hon Hou
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
COVID-19
PPIIs
Antiviral strategy
Drug discovery
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037021001112

Internet

http://www.sciencedirect.com/science/article/pii/S2001037021001112

Similar Items